Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-07-21
2000-10-31
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514171, 514178, 514182, A61K 3156
Patent
active
061403164
ABSTRACT:
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
REFERENCES:
patent: 3329579 (1967-07-01), Sau et al.
CA 104:200372, Buhl et al, 1985.
Adams Nathan William
Berliner David L.
Jennings-White Clive L.
Cook Rebecca
Pherin Corporation
LandOfFree
Estrene steroids as neurochemical initiators of change in human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrene steroids as neurochemical initiators of change in human , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrene steroids as neurochemical initiators of change in human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2051934